Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxidized regenerated cellulose vs tranexamic acid for perioperative blood loss in total hip arthroplasty
ChiCTR2300068724Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Feb 2023
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of tranexamic acid and oxidized and regenerated cellulose in hip osteoarthritis (3 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Perioperative blood loss. Planned start Feb 2023; status: not yet recruiting.
02
Drugs
tranexamic acidoxidized and regenerated cellulose
03
Conditions
hip osteoarthritis
Beyond the preview
Go deeper on ChiCTR2300068724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300068724.